???For patients who require a kidney transplant, the limited availability of organs underscores the urgent need for effective medicines that can help protect the survival of the transplanted organi for the patient,??? Novartis Pharmaceuticals division head David Epstein said. ???Our commitment to transplant patients exceeds 25 years, and Zortress is the latest addition to our growing portfolio.???